• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡1/程序性死亡配体1通路在慢性根尖周病变免疫微环境中的作用

Involvement of the Programmed Death 1/Programmed Death Ligand 1 Pathway in the Immune Microenvironment of Chronic Periapical Lesions.

作者信息

Song Yujin, Park Seohee, Jin Hyeseong, Hyun Byungyoon, Oh Kyu-Young

机构信息

College of Dentistry, Dankook University, Cheonan, Republic of Korea.

Department of Oral Pathology, College of Dentistry, Dankook University, Cheonan, Republic of Korea; Dankook University Dental Hospital, Cheonan, Republic of Korea.

出版信息

Int Dent J. 2025 Aug;75(4):100874. doi: 10.1016/j.identj.2025.100874. Epub 2025 Jun 25.

DOI:10.1016/j.identj.2025.100874
PMID:40570672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12264621/
Abstract

INTRODUCTION AND AIMS

This study aimed to determine the pathogenic role and clinicopathological significance of the immune microenvironment including the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway in chronic periapical lesions.

METHODS

A total of 20 chronic periapical lesions consisting of 10 periapical granulomas and 10 periapical cysts were included in this study. Immunohistochemistry was performed for immune cell populations, including PD-L1, PD-1, CD4, CD8, FOXP3, and CD20. Immune cell populations were quantitatively evaluated on digitized slides. The associations between each immune cell population and clinicopathological factors and between immune cell populations were statistically analysed.

RESULTS

Lesion size was positively associated with the density of PD-L1+ macrophages (P < .001, Fisher exact test; r = 0.455, P = .044, Pearson correlation analysis) and CD8+ cytotoxic T cells (P = .020, Fisher exact test; r = 0.471, P = .036, Pearson correlation analysis). No associations were found between immune cell populations and other clinicopathological factors, including age, sex, lesion location, and diagnosis. A moderate positive correlation was observed between the density of PD-L1+ macrophages and CD8+ cytotoxic T cells (r = 0.537, P = .015). The density of PD-1+ cells showed a strong positive correlation with the density of CD4+ helper T cells (r = 0.719, P < .001) and FOXP3+ regulatory T cells (r = 0.784, P < .001).

CONCLUSION

These findings suggest that cytotoxic T cells are implicated in the progression of chronic periapical lesions, which may be regulated by PD-L1+ macrophages. PD-1 may be involved in helper T cell exhaustion and regulatory T cell activity in chronic periapical lesions.

CLINICAL RELEVANCE

We demonstrated the involvement of PD-L1 and PD-1 in the regulation of T cell immunity in chronic periapical lesions. These findings suggest that activating the PD-1/PD-L1 pathway is a potential therapeutic strategy for chronic periapical lesions.

摘要

引言与目的

本研究旨在确定免疫微环境(包括程序性死亡1(PD-1)/程序性死亡配体1(PD-L1)通路)在慢性根尖周病变中的致病作用及临床病理意义。

方法

本研究共纳入20例慢性根尖周病变,其中包括10例根尖周肉芽肿和10例根尖周囊肿。对免疫细胞群体进行免疫组织化学检测,包括PD-L1、PD-1、CD4、CD8、FOXP3和CD20。在数字化切片上对免疫细胞群体进行定量评估。对各免疫细胞群体与临床病理因素之间以及免疫细胞群体之间的相关性进行统计学分析。

结果

病变大小与PD-L1+巨噬细胞密度呈正相关(P <.001,Fisher精确检验;r = 0.455,P =.044,Pearson相关分析)以及与CD8+细胞毒性T细胞密度呈正相关(P =.020,Fisher精确检验;r = 0.471,P =.036,Pearson相关分析)。未发现免疫细胞群体与其他临床病理因素之间存在关联,包括年龄、性别、病变位置和诊断。观察到PD-L1+巨噬细胞密度与CD8+细胞毒性T细胞密度之间存在中度正相关(r = 0.537,P =.015)。PD-1+细胞密度与CD4+辅助性T细胞密度呈强正相关(r = 0.719,P <.001)以及与FOXP3+调节性T细胞密度呈强正相关(r = 0.784,P <.001)。

结论

这些发现表明细胞毒性T细胞与慢性根尖周病变的进展有关,这可能受PD-L1+巨噬细胞调节。PD-1可能参与慢性根尖周病变中辅助性T细胞耗竭和调节性T细胞活性。

临床意义

我们证明了PD-L1和PD-1参与慢性根尖周病变中T细胞免疫的调节。这些发现表明激活PD-1/PD-L1通路是慢性根尖周病变的一种潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/9366d4e85da1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/be8b0f0c8e07/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/337b31e26a5b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/5e709ca68920/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/9366d4e85da1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/be8b0f0c8e07/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/337b31e26a5b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/5e709ca68920/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a35/12264621/9366d4e85da1/gr4.jpg

相似文献

1
Involvement of the Programmed Death 1/Programmed Death Ligand 1 Pathway in the Immune Microenvironment of Chronic Periapical Lesions.程序性死亡1/程序性死亡配体1通路在慢性根尖周病变免疫微环境中的作用
Int Dent J. 2025 Aug;75(4):100874. doi: 10.1016/j.identj.2025.100874. Epub 2025 Jun 25.
2
Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8 T cell activity and biomarker during the evolution of type 1 diabetes.β细胞细胞外囊泡PD-L1作为1型糖尿病进展过程中CD8 T细胞活性的新型调节因子和生物标志物。
Diabetologia. 2025 Feb;68(2):382-396. doi: 10.1007/s00125-024-06313-2. Epub 2024 Nov 7.
3
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.在结直肠癌模型中,溶瘤呼肠孤病毒与PD1-PDL1抑制剂联合使用时可增强CEA免疫疗法的效果。
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
4
Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.描述分化型甲状腺癌前沿的免疫浸润情况。
Thyroid. 2024 Aug;34(8):999-1006. doi: 10.1089/thy.2024.0072. Epub 2024 Jul 12.
5
PD-L1 Expression and Tumor Microenvironment Dynamics in Diffuse Large B-Cell Lymphoma: Immunophenotypic Insights.弥漫性大B细胞淋巴瘤中PD-L1表达与肿瘤微环境动态变化:免疫表型见解
J Med Life. 2025 May;18(5):463-471. doi: 10.25122/jml-2025-0078.
6
C-X-C chemokine receptor type 5CD8 T cells as immune regulators in hepatitis Be antigen-positive chronic hepatitis B under interferon-alpha treatment.C-X-C趋化因子受体5型CD8 T细胞作为α干扰素治疗下乙肝e抗原阳性慢性乙型肝炎的免疫调节因子
World J Gastroenterol. 2025 Jan 21;31(3):99833. doi: 10.3748/wjg.v31.i3.99833.
7
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.程序性死亡受体1配体(PD-L1)诊断测试:评分算法和测试验证指标的系统文献综述
Diagn Pathol. 2018 Feb 9;13(1):12. doi: 10.1186/s13000-018-0689-9.
8
Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.淋巴细胞亚群表达与脓毒症 PD-1/PD-L1 血清浓度的关系 - 一项初步研究。
Crit Care. 2018 Apr 17;22(1):95. doi: 10.1186/s13054-018-2020-2.
9
Pseudo-color enhancement of CBCT images as a diagnostic tool for radicular cysts and periapical granulomas: A clinical feasibility study.CBCT图像的伪彩色增强作为诊断根端囊肿和根尖肉芽肿的工具:一项临床可行性研究。
Clin Oral Investig. 2025 Jul 3;29(7):371. doi: 10.1007/s00784-025-06425-y.
10
The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.食管癌组织中PD-1通路相关免疫细胞的分布特征及其预后意义。
PLoS One. 2025 Jun 30;20(6):e0325349. doi: 10.1371/journal.pone.0325349. eCollection 2025.

本文引用的文献

1
The heterogeneity of T cell infiltration in human periapical lesions.人类根尖周病变中T细胞浸润的异质性。
BMC Oral Health. 2025 Feb 19;25(1):261. doi: 10.1186/s12903-025-05621-2.
2
Correlation between PD-1/PD-L1 and RANKL/OPG in chronic apical periodontitis model of Sprague-Dawley rats.PD-1/PD-L1 与 RANKL/OPG 在 Sprague-Dawley 大鼠慢性根尖周炎模型中的相关性。
Odontology. 2024 Oct;112(4):1113-1122. doi: 10.1007/s10266-024-00911-7. Epub 2024 Mar 25.
3
Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade.
牙源性癌中的肿瘤免疫微环境:免疫检查点阻断治疗潜力的评估。
J Oral Pathol Med. 2024 Mar;53(3):217-225. doi: 10.1111/jop.13525. Epub 2024 Mar 6.
4
Correlation Between Proinflammatory Cytokine Expression and Clinical Data in Apical Granuloma.根尖肉芽肿中促炎细胞因子表达与临床数据的相关性
J Endod. 2024 Apr;50(4):499-505. doi: 10.1016/j.joen.2024.01.018. Epub 2024 Feb 2.
5
COVID-19 Severity in Patients With Apical Periodontitis: A Case Control Study.伴有尖周炎的 COVID-19 患者的严重程度:一项病例对照研究。
Int Dent J. 2024 Aug;74(4):736-745. doi: 10.1016/j.identj.2024.01.002. Epub 2024 Jan 20.
6
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components.PD-1/PD-L1通路在免疫相关疾病中的治疗潜力:基于固有免疫和适应性免疫成分
Biomed Pharmacother. 2023 Nov;167:115569. doi: 10.1016/j.biopha.2023.115569. Epub 2023 Sep 26.
7
PD-1/PD-L1 pathway: A double-edged sword in periodontitis.PD-1/PD-L1 通路:牙周炎的双刃剑。
Biomed Pharmacother. 2023 Mar;159:114215. doi: 10.1016/j.biopha.2023.114215. Epub 2023 Jan 9.
8
Effectiveness of probiotics in apical periodontitis progression: A scoping review and implications for research.益生菌对根尖周炎进展的疗效:范围综述及对研究的启示。
Aust Endod J. 2023 Sep;49 Suppl 1:528-536. doi: 10.1111/aej.12728. Epub 2022 Dec 16.
9
Presence of langerhans cells, regulatory T cells (Treg) and mast cells in asymptomatic apical periodontitis.无症状性根尖周炎中朗格汉斯细胞、调节性 T 细胞(Treg)和肥大细胞的存在。
Braz Oral Res. 2020;34:e108. doi: 10.1590/1807-3107bor-2020.vol34.0108. Epub 2020 Aug 28.
10
The Role of PD-1 in Acute and Chronic Infection.PD-1 在急性和慢性感染中的作用。
Front Immunol. 2020 Mar 24;11:487. doi: 10.3389/fimmu.2020.00487. eCollection 2020.